Recombinant activated factor VII in approved indications: Update on safety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant activated factor VII in approved indications: Update on safety

Published:2018-07 Issue:4 Volume:24 Page:e275-e277
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Neufeld E. J.¹,Négrier C.²,Benchikh el Fegoun S.³^ORCID,Cooper D. L.⁴^ORCID,Rojas-Rios A.⁵,Seremetis S.⁴

Affiliation:

1. St. Jude Children's Research Hospital; Memphis TN USA

2. Unite d'Hemostase Clinique; Hopital Cardiologique Louis Pradel; University Lyon I; Lyon France

3. Novo Nordisk Health Care AG; Zürich Switzerland

4. Novo Nordisk Inc.; Plainsboro NJ USA

5. Novo Nordisk A/S; Søborg Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13547/fullpdf

Reference10 articles.

1. Novo Nordisk NovoSeven ® RT, Coagulation Factor VIIa (Recombinant)

2. Novo Nordisk NovoSeven ® summary of product characteristics

3. Novo Nordisk Canada Inc NiaStase RT ® product monograph

4. Novo Nordisk NovoSeven summary of product characteristics 2017

5. Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes;Shapiro;Ther Adv Drug Saf,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage;Journal of Clinical Medicine;2024-05-16

2. Pulmonary hemorrhage in cystic fibrosis: a review of current data;PULMONOLOGIYA;2023-12-13

3. The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors;Haemophilia;2021-10-11

4. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia;Thrombosis and Haemostasis;2020-10-29

5. Mersin’de Tip 1 Aort Diseksiyonunda doku yapıştırıcısı kullanımının kanama üzerine etkisi: Kanama kontrolünün tarihsel kısa analizi;Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi;2020-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3